Sponsors (2)
The bill reduces legal barriers to fentanyl/xylazine test kit possession, distribution, and use—supporting harm reduction and outreach—while offering no guaranteed new funding and raising concerns about enforcement signaling, prosecutorial limits, and vendor/regulatory uncertainty.
People who use drugs (including low-income and rural individuals) can legally possess and use fentanyl/xylazine test equipment without fear of paraphernalia prosecution, enabling more on-site testing and reducing overdose risk.
Sellers and distributors can lawfully supply fentanyl/xylazine detection tools, increasing availability of harm-reduction supplies in communities and for programs that serve people at risk of overdose.
First responders and public-health programs can more easily acquire and transport fentanyl/xylazine detection equipment to support testing, outreach, and safer responses.
Using an explicit, punitive-sounding short title could signal stricter enforcement priorities and potentially increase criminalization risk for people who use drugs.
The broader paraphernalia exemption may limit prosecutors' ability to use paraphernalia charges in related investigations, reducing an investigative tool for law enforcement.
Vendors could face increased demand and uncertain liability without clear federal standards for approved detection devices, creating regulatory and economic uncertainty for small businesses selling these tools.
Based on analysis of 2 sections of legislative text.
Exempts fentanyl- and xylazine-detection equipment from federal drug paraphernalia prohibitions and related seizure/penalty authorities.
Exempts testing devices that detect fentanyl or xylazine from the federal drug paraphernalia law, so possessing, selling, transporting, importing, or exporting such detection equipment is not a crime or subject to seizure under that statute. The bill narrowly amends federal law to clarify that penalties, seizure/forfeiture, and the definition of "drug paraphernalia" do not apply to equipment whose intended use is to indicate the presence of fentanyl or xylazine in a compound.
Official title: To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful.
Introduced February 25, 2025 by Jasmine Crockett · Last progress February 25, 2025